SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
14 federal contract opportunities classified as Pharmaceutical Research.
AI Summary
The Department of Health and Human Services, specifically the Food and Drug Administration, has issued a cancellation notice for the requirement FDAFO121683 regarding post-market bioequivalence studies. This opportunity is categorized under health services and focuses on pharmaceutical research.
MD
AI Summary
This opportunity involves post-market bioequivalence studies for the Department of Health and Human Services, specifically the Food and Drug Administration. The response date has been extended to September 28, 2025, at 12 PM EST. All other terms and conditions remain unchanged.
MD
AI Summary
The National Institutes of Health is seeking proposals for a toxicity evaluation of YC1 in mice with humanized SULT1A1 and wild type SULT1A1. This research aims to establish the therapeutic window for YC1, which targets cancer cells expressing SULT1A1. Interested parties should prepare for a head-to-head comparison stu…
MD
AI Summary
The Department of Health and Human Services is soliciting proposals for post-market bioequivalence studies. Questions are due by 10:00 AM Eastern on August 13, 2025, and proposals must be submitted by 10:00 AM Eastern on August 21, 2025. Interested parties should follow the specified subject line for submissions.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services is seeking information on the availability of qualified sources to provide a covalent screening library of small molecules. This Sources Sought notice aims to identify companies capable of supplying 1,000 small molecules with validated biological activities for high-throughpu…
MD
AI Summary
The Department of Health and Human Services, specifically the Food and Drug Administration, has issued a sole source notice. This opportunity is categorized under NAICS code 541714, focusing on health services and pharmaceutical research. Interested parties should refer to the attached notice for further details.
MD
AI Summary
The U.S. Army Medical Research Acquisition Activity (USAMRAA) plans to negotiate a sole source contract with Portland State University for research on Novel Antimalarial Drug Targets. This project will support the Walter Reed Army Institute of Research's investigation into compound WR936909's Structure-Activity Relatio…
MD
AI Summary
The Department of Veterans Affairs is issuing a Special Notice regarding a sole source award for Research Study Investigational Drug Services for the VA CT Healthcare System. This opportunity falls under NAICS code 541690 and is not a solicitation. Interested parties may contact the Contracting Officer, Tara Dossiema, …
ME
AI Summary
The Department of Health and Human Services, specifically the Food and Drug Administration, is seeking bids for an Automated Dry Heat Diffusion System with 24 vertical cells. This system will facilitate critical research on the performance, quality, and safety of transdermal and topical drug products through extensive …
MD
AI Summary
The Department of Defense's Defense Health Agency (DHA) is seeking information through a Request for Information (RFI) regarding novel antimalarial drug targets. This non-commercial research and development project will span two years, starting on September 30, 2025, and concluding on September 29, 2027. Work will be c…
MD
AI Summary
The National Institutes of Health has issued Amendment Six for the 2026 NIAID DMID Omnibus Broad Agency Announcement, updating the proposal due date for Research Area 001 to February 21, 2025, at 3:00 PM EST. The due date for Research Area 002 remains January 21, 2025. Offerors must submit proposals according to the sp…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is seeking technical consulting services and data analysis related to glucagon-like peptide-1 analogues for addressing alcohol use disorder. This opportunity is a combined synopsis/solicitation under FAR Subpart 12.6, focusing on commercial services. Interested bidders should prepare t…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institute on Drug Abuse is seeking Capability Statements from organizations to provide technical consulting services and data analysis on glucagon-like peptide-1 analogues for addressing alcohol use disorder. This opportunity is categorized as a Source Sought and is not intended for small businesses.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is seeking proposals for the competitive renewal of a contract focused on evaluating pharmacotherapies for drug use disorders in rodents, including abuse liability testing. This opportunity is a service contract and is not subject to Simplified Acquisition Procedures.
MD
Common questions about finding and winning Pharmaceutical Research government contracts.